Menu Search
Equities

Vitrolife AB

VTFN:FRA

Vitrolife AB

Actions
  • Price (EUR)14.00
  • Today's Change-0.03 / -0.21%
  • Shares traded420.00
  • 1 Year change-30.28%
  • Beta--
Data delayed at least 15 minutes, as of Apr 30 2024 20:49 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

  • Revenue in SEK (TTM)3.50bn
  • Net income in SEK-3.84bn
  • Incorporated1989
  • Employees1.13k
  • Location
    Vitrolife ABGustaf Werners gata 2, Vastra FrolundaGOETEBORG 421 32SwedenSWE
  • Phone+46 317218000
  • Fax+46 317218099
  • Websitehttps://www.vitrolife.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.